Our diabetes genetic testing panel is designed to provide comprehensive insights into your genetic predisposition to diabetes. By analyzing specific genetic markers associated with diabetes risk, we offer valuable information that can inform personalized approaches to disease management.
Our state-of-the-art technology and advanced analysis techniques ensure accurate and reliable results, empowering individuals with the knowledge they need to take proactive steps towards better health.
Our testing allows for early identification of genetic risk factors for diabetes, enabling proactive management and prevention strategies
Armed with genetic insights, individuals can make informed decisions about lifestyle factors such as diet and exercise
By identifying genetic risk factors early on, individuals can implement targeted interventions to reduce their risk of developing diabetes
Explore the Genetic Markers Included in Our Cancer Genetic Testing Panel
ACP5, ADA2, ADAM17, ADAR, AP1S3, ASAH1, CARD14, COPA, DDX58, ELANE, HAX1, HTR1A, IFIH1, IL10RA, IL10RB, IL1RN, IL36RN, ISG15, LPIN2, MEFV, MVK, NLRC4, NLRP1, NLRP12, NLRP3, NOD2, OTULIN, PIK3CD, PIK3R1, PLCG2, POLA1, POMP, PRG4, PRKCD, PSENEN, PSMA3, PSMB4, PSMB8, PSMG2, PSTPIP1, RBCK1, RIPK1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, SH3BP2, SLC29A3, TMEM173, TNFAIP3, TNFRSF11A, TNFRSF1A, TREX1, TRNT1, USP18, WDR1
© 2024 ExpressGene. All rights reserved. Unless otherwise indicated, all product names, service names, and logos featured on this website are trademarks owned by ExpressGene, its subsidiaries, or its affiliates. Any use of ExpressGene trademarks, trade names, or trade dress on this website must be authorized in writing by ExpressGene, except for the purpose of identifying ExpressGene’s products or services.